Sage Journals: Discover world-class research

Open access

Case report

First published 2017-1

Long-Term Response and Possible Cure of Patients With B-Cell Malignancies With Dose-Escalated Rituximab

Lauren M. Jacobs, Peter H. Wiernik, Janice P. Dutcher [...]

Journal of Investigative Medicine High Impact Case Reports

Retricted access

Case report

First published 2019-7

Case series of unique adverse events related to the use of ibrutinib in patients with B-cell malignancies—A single institution experience and a review of literature

Hira Shaikh, Ahmed Khattab, Muhammad S Faisal [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2020

Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies

Feng Zhu, Guoqing Wei, Mingming Zhang [...]

Cell Transplantation

Open access

Review article

First published 2022

The potential of pirtobrutinib in multiple B-cell malignancies

Jeffrey L. Jensen, Anthony R. Mato, Camila Pena [...]

Therapeutic Advances in Hematology

Open access

Research article

First published 2021

Incidence and Risk Factors Associated with Infection after Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory B-cell Malignancies

Feng Zhu, Guoqing Wei, Yandan Liu [...]

Cell Transplantation

Retricted access

Research article

First published 2019-04

Induced CD20 Expression on B-Cell Malignant Cells Heightened the Cytotoxic Activity of Chimeric Antigen Receptor Engineered T Cells

Yingxi Xu, Saisai Li, Ying Wang [...]

Human Gene Therapy

Retricted access

Review article

First published 2024-10

Pirtobrutinib: A New and Distinctive Treatment Option for B-Cell Malignancies

Madeline D. Schultze, David J. Reeves

Annals of Pharmacotherapy

Free access

Abstract

First published 1989-1

Detection of intracytoplasmic immunoglobulin by flow cytometry in B-cell malignancies.

R H Bardales, A M Al-Katib, A Carrato [...]

Journal of Histochemistry & Cytochemistry

Open access

Review article

First published 2020

CAR T-cell immunotherapy of B-cell malignancy: the story so far

Leena Halim, John Maher

Therapeutic Advances in Vaccines and Immunotherapy

Free access

Review article

First published 2014-8

Bruton’s tyrosine kinase inhibitors and their clinical potential in the treatment of B-cell malignancies: focus on ibrutinib

Amin Aalipour, Ranjana H. Advani

Therapeutic Advances in Hematology

Search results